{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T21:43:29Z","timestamp":1748641409922},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.thromres.2012.08.278","type":"journal-article","created":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T20:07:05Z","timestamp":1348862825000},"page":"S61-S62","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S1","title":["Antithrombotic agents and invasive procedures - Hematologist point of view"],"prefix":"10.1016","volume":"130","author":[{"given":"T.P.","family":"Lecompte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"S2","key":"10.1016\/j.thromres.2012.08.278_bb0005","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2012.08.278_bb0010","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/j.1538-7836.2011.04432.x","article-title":"Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents","volume":"9","author":"Levi","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"S1","key":"10.1016\/j.thromres.2012.08.278_bb0015","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1002\/ajh.23165","article-title":"Reversal of antithrombotic agents","volume":"87","author":"Bauer","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2012.08.278_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.thromres.2010.07.024","article-title":"Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography","volume":"127","author":"Hacquard","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2012.08.278_bb0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1160\/TH12-03-0179","article-title":"Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban","volume":"108","author":"Marlu","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.08.278_bb0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1160\/TH12-05-0330","article-title":"Reverse engineering for new oral anticoagulants: non-specific reversal agents and the anticoagulant activity of dabigatran and rivaroxaban","volume":"108","author":"Levi","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.08.278_bb0035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.acvd.2011.09.001","article-title":"Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis","volume":"104","author":"Si\u00e9","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.thromres.2012.08.278_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1160\/TH10-07-0434","article-title":"Efficacy of prothrombin complex concentrate to reverse the anticoagulant effect of the pentasaccharide fondaparinux in a rabbit model","volume":"105","author":"Godier","year":"2011","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812006500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812006500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T07:27:41Z","timestamp":1542698861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384812006500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":8,"alternative-id":["S0049384812006500"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2012.08.278","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}